✦ LIBER ✦

Mechanisms of resistance to topoisomerase I-targeting drugs

✍ Scribed by Rasheed, Zeshaan A; Rubin, Eric H

Book ID: 110068020
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 235 KB
Volume: 22
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1206935

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topoisomerase I in multiple drug resista

Topoisomerase I in multiple drug resistance

✍ Augusto Pessina 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 783 KB

Topoisomerase I inhibitors and drug resi

Topoisomerase I inhibitors and drug resistance

✍ Ralph E. Parchment; Augusto Pessina 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 124 KB

Enhancement of radiotherapy with DNA top

Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs

✍ Allan Y. Chen; Rachel Chou; Shyh-Jen Shih; Derick Lau; David Gandara 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 176 KB

DNA topoisomerase II mutations and resis

DNA topoisomerase II mutations and resistance to anti-tumor drugs

✍ Yegor S. Vassetzky; Gian-Carlo Alghisi; Susan M. Gasser 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 856 KB

Resistance to antiplatelet drugs: molecu

Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection

✍ M. CATTANEO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

High antineoplastic activity of new hete

High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs

✍ Hermann Lage; Esin Aki-Sener; Ismail Yalcin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 237 KB

## Abstract Twenty previously synthesized fused heterocyclic DNA‐topoisomerase II (Topo II)‐inhibiting compounds were investigated for their potential efficacy in various human cancer cell lines that were derived from different tumor entities. Moreover, different multidrug‐resistant variants of the